Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice.

Frau R, Pillolla G, Bini V, Tambaro S, Devoto P, Bortolato M.

Psychoneuroendocrinology. 2013 Apr;38(4):542-51. doi: 10.1016/j.psyneuen.2012.07.014. Epub 2012 Aug 9.

2.

Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation.

Frau R, Bini V, Pes R, Pillolla G, Saba P, Devoto P, Bortolato M.

Psychoneuroendocrinology. 2014 Jan;39:204-13. doi: 10.1016/j.psyneuen.2013.09.014. Epub 2013 Sep 21.

3.

The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.

Frau R, Mosher LJ, Bini V, Pillolla G, Pes R, Saba P, Fanni S, Devoto P, Bortolato M.

Psychoneuroendocrinology. 2016 Jan;63:59-67. doi: 10.1016/j.psyneuen.2015.09.014. Epub 2015 Sep 24.

4.

Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation.

Devoto P, Frau R, Bini V, Pillolla G, Saba P, Flore G, Corona M, Marrosu F, Bortolato M.

Psychoneuroendocrinology. 2012 Oct;37(10):1630-45. doi: 10.1016/j.psyneuen.2011.09.018. Epub 2011 Oct 24.

5.

Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.

Ralph-Williams RJ, Lehmann-Masten V, Geyer MA.

Neuropsychopharmacology. 2003 Jan;28(1):108-18.

6.

Inhibition of phosphodiesterase 10A has differential effects on dopamine D1 and D2 receptor modulation of sensorimotor gating.

Gresack JE, Seymour PA, Schmidt CJ, Risbrough VB.

Psychopharmacology (Berl). 2014 May;231(10):2189-97. doi: 10.1007/s00213-013-3371-7. Epub 2013 Dec 21.

7.

Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress.

Frau R, Abbiati F, Bini V, Casti A, Caruso D, Devoto P, Bortolato M.

Schizophr Res. 2015 Nov;168(3):640-8. doi: 10.1016/j.schres.2015.04.044. Epub 2015 May 18.

8.

Activation of nociceptin/orphanin FQ peptide receptors disrupts visual but not auditory sensorimotor gating in BALB/cByJ mice: comparison to dopamine receptor agonists.

Ces A, Reiss D, Walter O, Wichmann J, Prinssen EP, Kieffer BL, Ouagazzal AM.

Neuropsychopharmacology. 2012 Jan;37(2):378-89. doi: 10.1038/npp.2011.175. Epub 2011 Aug 31.

9.

Antipsychotic-like properties of 5-alpha-reductase inhibitors.

Bortolato M, Frau R, Orrù M, Bourov Y, Marrosu F, Mereu G, Devoto P, Gessa GL.

Neuropsychopharmacology. 2008 Dec;33(13):3146-56. doi: 10.1038/npp.2008.39. Epub 2008 Mar 19.

10.

Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.

Auclair AL, Kleven MS, Besnard J, Depoortère R, Newman-Tancredi A.

Neuropsychopharmacology. 2006 Sep;31(9):1900-9. Epub 2006 Jan 18.

11.

Heritable strain differences in sensitivity to the startle gating-disruptive effects of D2 but not D3 receptor stimulation.

Weber M, Chang WL, Breier M, Ko D, Swerdlow NR.

Behav Pharmacol. 2008 Dec;19(8):786-95. doi: 10.1097/FBP.0b013e32831c3b2b.

12.

Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.

Bortolato M, Aru GN, Fà M, Frau R, Orrù M, Salis P, Casti A, Luckey GC, Mereu G, Gessa GL.

Neuropsychopharmacology. 2005 Mar;30(3):561-74.

13.

Heritable differences in the dopaminergic regulation of sensorimotor gating. II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition.

Swerdlow NR, Shoemaker JM, Auerbach PP, Pitcher L, Goins J, Platten A.

Psychopharmacology (Berl). 2004 Aug;174(4):452-62. Epub 2003 May 21.

PMID:
15300359
14.

Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.

LaHoste GJ, Marshall JF.

Behav Brain Res. 1990 May 28;38(3):233-42.

PMID:
1973041
16.
17.

Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet.

Wakabayashi C, Numakawa T, Ooshima Y, Hattori K, Kunugi H.

Psychopharmacology (Berl). 2015 Dec;232(24):4393-400. doi: 10.1007/s00213-015-4068-x. Epub 2015 Sep 11.

PMID:
26359228
18.
19.

Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice.

Yarkov AV, Hanger D, Reploge M, Joyce JN.

Pharmacol Biochem Behav. 2003 Dec;76(3-4):551-62.

PMID:
14643855
20.

Toward understanding the biology of a complex phenotype: rat strain and substrain differences in the sensorimotor gating-disruptive effects of dopamine agonists.

Swerdlow NR, Martinez ZA, Hanlon FM, Platten A, Farid M, Auerbach P, Braff DL, Geyer MA.

J Neurosci. 2000 Jun 1;20(11):4325-36.

Supplemental Content

Support Center